Graphite Therapeutics Private Limited
About Graphite Therapeutics Private Limited
Data last updated:
Graphite Therapeutics Private Limited is a private limited company based in Oddanchataram, Tamil Nadu, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 22 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U85110TZ2013PTC019524. Its GSTIN is 33AAFCG2648J1ZL (Tamil Nadu).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Govindan Vaidyanathan (Managing Director) and Kannan Sivakumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.47 – A6 Dindigul Palani Salai North Side, Oddanchataram, Tamil Nadu, India – 624619.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.49 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹1.65 Lakh (net margin -30%) and EBITDA of -₹1.65 Lakh (EBITDA margin -30%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Graphite Therapeutics Private Limited's registered office is in Oddanchataram, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.47 – A6 Dindigul Palani Salai North Side, Oddanchataram, Tamil Nadu, India – 624619
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Graphite Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Graphite Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Graphite Therapeutics Private Limited, buy the company report.
Financials of Graphite Therapeutics Private Limited
FY 2025 filings availableGraphite Therapeutics Private Limited reported revenue of ₹5.49 Lakh (down 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 28% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -30% | ||||
| Net Profit Margin | -30% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Graphite Therapeutics Private Limited, buy the company report.
Board of directors of Graphite Therapeutics Private Limited
Graphite Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannan Sivakumar | Director | 22 May 2013 | 13 Years 5 Months | Current |
| Govindan Vaidyanathan | Managing Director | 22 May 2013 | 13 Years 5 Months | Current |
Auditor
Graphite Therapeutics Private Limited is audited by R GOVINDAN & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R GOVINDAN & CO | FY 2017 | 007014S |
Shareholding
The shareholding of Graphite Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Graphite Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Graphite Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Graphite Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Graphite Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCG2648J1ZL | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Graphite Therapeutics Private Limited, buy the company report.
Recent activity
Graphite Therapeutics Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Govindan Vaidyanathan was appointed as Managing Director on 22 May 2013.
Frequently asked questions
Graphite Therapeutics is an active private limited company based in Oddanchataram, Tamil Nadu, India. The company works in wholesale, within the trading industry. It was incorporated on 22 May 2013 (13+ years old) and is registered under CIN U85110TZ2013PTC019524.
Graphite Therapeutics has 2 current directors:
- Govindan Vaidyanathan - Managing Director
- Kannan Sivakumar - Director
The latest financial statements of Graphite Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Graphite Therapeutics is 33AAFCG2648J1ZL, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Graphite Therapeutics is U85110TZ2013PTC019524. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Graphite Therapeutics was incorporated on 22 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Coimbatore.
Govindan Vaidyanathan was appointed as Managing Director on 22 May 2013. Kannan Sivakumar was appointed as Director on 22 May 2013.
The registered office of Graphite Therapeutics is at No.47 – A6 Dindigul Palani Salai North Side, Oddanchataram, Tamil Nadu, India – 624619.
Graphite Therapeutics operates in the trading industry, in the wholesale segment.
The compliance status of Graphite Therapeutics is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.